Reversible Cancer Therapeutics-related Cardiac Dysfunction Complicating Intra-cardiac Thrombi

Epirubicin-based chemotherapy carries a risk of inducing heart failure, although the frequency is rare. Bevacizumab, an anti-vascular endothelial growth factor monoclonal antibody, has recently been widely used in patients with recurrent breast cancer as a first-line chemotherapeutic agent. Heart fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsujinaga, Shingo, Iwano, Hiroyuki, Oshino, Tomohiro, Kadosaka, Takahide, Mizuguchi, Yoshifumi, Motoi, Ko, Chiba, Yasuyuki, Koya, Taro, Temma, Taro, Kamiya, Kiwamu, Fukushima, Arata, Koizumi, Takuya, Sato, Tomoya, Takenaka, Sakae, Tada, Atsushi, Ishizaka, Suguru, Sarashina, Miwa, Omote, Kazunori, Kamada, Rui, Konishi, Takao, Sato, Takuma, Nagai, Toshiyuki, Yamashita, Hiroko, Anzai, Toshihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516330/
https://www.ncbi.nlm.nih.gov/pubmed/32493855
http://dx.doi.org/10.2169/internalmedicine.4792-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516330/
https://www.ncbi.nlm.nih.gov/pubmed/32493855
http://dx.doi.org/10.2169/internalmedicine.4792-20

Ejemplares similares